Back to all studies
Active Not RecruitingNCT06539611

Prospective Cohort Study of a Population at Risk of Psychotic Transition

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in France.

Schizophrenia, At-risk Mental StatesOtherFrom 15 Years to 30 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06539611. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether a Population at Risk of Psychotic Transition Prospective Cohort Study of a Population at Risk of Psychotic Transition may be useful for people experiencing schizophrenia.

What would participation involve?

Participants may receive a Population at Risk of Psychotic Transition Prospective Cohort Study of a Population at Risk of Psychotic Transition, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in France.

Who is it mainly for?

This study appears to be mainly for people with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Mirvat B HAMDAN-DUMONT in Limoges. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually being able to understand the study and consent, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: November 18, 2024
Recruitment status
Active Not Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Centre Hospitalier Esquirol
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
France
Age range
From 15 Years to 30 Years
Official registry ID
NCT06539611
Official title
Prospective Cohort Study of a Population at Risk of Psychotic Transition
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06539611. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in France.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Why is the study type not clearly categorized?

The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 15 Years to 30 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What risks or points should I check?

The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Centre Hospitalier Esquirol, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me